Global Custom Market Research Reports Provider Company

phone

Non-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025

  • Published Date: 31 Aug 2017
  • Number of Pages: 65
  • Category: Pharmaceuticals
  • Country: Global
Non-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025

Summary

The NSCLC therapeutics market is a rapidly evolving field in which new developments are constantly influencing the landscape. The Forecast Update is designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand how these events will impact the market forecast.

Scope

Key events covered in the Dynamic Market Forecast include -
- Regulatory filings
- Approval decisions
- Pricing changes
- Patent litigation
- Clinical trial data announcements
- Clinical trial failures
- Clinical trial timeline updates

Components of the slide deck include -
- Timeline of market-impacting events
- Key clinical trial landscape updates
- Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
- Overview of updates to the forecast model based on anticipated future impact of events
- Forward-looking events calendar listing expected key updates to the NSCLC competitive space in the next quarter

Reasons to buy

- Recent regulatory events
- Recent commercial events
- Recent clinical events
- Market dynamics in the frontline NSCLC setting
- Landscape changes in the EGFR-mutant NSCLC setting
- Projected treatment algorithm shifts in the ALK-mutant NSCLC setting
Publisher Name : GlobalData
1. Dynamic Market Forecast Overview 5
1.1 Related Reports 6
1.2 Upcoming Related Reports 7
2. Executive Summary 8
2.1 Key Events in Update 9-10
2.2 Updates to Treatment Algorithms 11
2.3 Clinical Trial Landscape Updates 12-13
2.4 Pipeline Landscape Updates 14
2.5 Market Insight on Key Events 15
3. Event 1: Market Dynamics Shift in Frontline NSCLC 16
3.1 Key Updates to the Frontline Non-squamous Setting 17
3.2 Merck & Co., Keytruda (pembrolizumab) 18-19
3.3 AstraZeneca, Imfinzi (durvalumab) + tremelimumab 20-21
3.4 Pfizer and Merck KGaA , Bavencio (avelumab) 22
3.5 Roche, Tecentriq (atezolizumab) 23
3.6 Novartis, Tafinlar (dabrafenib) + Mekinist (trametinib) 24
3.7 Additional Clinical Trial Updates- Frontline Setting 25-26
3.8 Summary/Trends 27
3.9 Sources 28
4. Event 2: Weak Competition in the EGFRm+ Segment Creates Opportunity for Tagrisso 29
4.1 Key Updates to the EGFRm+ Segment 30
4.2 AstraZeneca, Tagrisso (osimertinib) 31-33
4.3 Pfizer, dacomitinib 34
4.4 Additional Clinical Trial Updates- EGFRm+ Setting 35
4.5 Summary/Trends 36
4.6 Sources 37
5. Event 3: New SOC Anticipated in the ALKm+ 1L Setting 38
5.1 Key Updates to the ALKm+ Setting 39
5.2 Roche, Alecensa (alectinib) 40
5.3 Takeda, Alunbrig (brigatinib) 41
5.4 Pfizer, lorlatinib 42
5.5 Summary/Trends 43
5.6 Sources 44
6. Other Events of Interest 45
6.1 Various Developers 46-47
6.2 Sources 48
7. Dynamic Market Forecast Highlights 49
7.1 Updates to Frontline NSCLC Segment 50
7.2 Updates to EGFRm+ NSCLC Segment 51
7.3 Updates to ALKm+ NSCLC Segment 52
7.4 Selected Additional Forecast Updates 53
8. Events Calendar 54
8.1 Key Clinical Events Expected in Q4 2017 55-56
9. Appendix 57
9.1 Methodology 58
9.2 Primary Research 59-60
9.3 About the Authors 61-62
9.4 About GlobalData 63
9.5 Contact Us 64
9.6 Disclaimer 65

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H1 2018, provides an overview

View Report

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018- JSB Market Research published a new report on clinical trial report, Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario.

View Report

The global market size of Drugs for Non-small Cell Lung Cancer is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports